MarketResearchNest.com adds “Global Clinical Trial Management System (CTMS) Market 2017-2021” new report to its research database. The report spread across 84 pages with table and figures in it.
Research analysts forecast the global clinical trial management system (CTMS) market to grow at a CAGR of 12.98% during the period 2017-2021.
Clinical trials are defined as research studies undertaken to successfully test a drug or a medical device before launching the product in the market. These studies are pivotal as the data generated in these studies forms the basis for the approval process of a drug or a medical device. Typically, these clinical trials are divided into five phases with each phase as critical as any other. It takes approximately 12 years to successfully complete a clinical trial, and the typical cost estimate of a clinical trial is $800 million to $1.2 billion with a success rate of 12% that the drug will get approved in the market or not.
Covered in this report
The report covers the present scenario and the growth prospects of the global clinical trial management system (CTMS) market for 2017-2021. To calculate the market size, the report considers the revenue generated from the retail sales of CTMS components that comprise software and services.
Browse full table of contents and data tables at
The market is divided into the following segments based on geography:
Technavio’s report, Global Clinical Trial Management System (CTMS) Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Technavio recognizes the following companies as the key players in the global clinical trial management system (CTMS) market: Bioclinica, Medidata, Oracle, and PAREXEL
Other Prominent Vendors in the market are: ArisGlobal, Bio-Optronics, DATATRAK, DSG, ERT Clinical, FORTE, MedNet Solutions, Merge, Trial by Fire Solutions, and Veeva Systems.
Commenting on the report, an analyst from Research team said: “The latest trend gaining momentum in the market is increasing outsourcing of clinical trial process. With increased emphasis on R&D investments and drug discovery, several small companies have resorted to outsourcing their drug discovery process to subcontract laboratories, while limiting themselves to manufacturing and marketing activities. The number of subcontract laboratories has been growing rapidly since 2011, and this trend will continue over the forecast period. In the last decade, industry has transformed operations of clinical research from a vertical and fixed reporting model, with a large number of in-house professionals devoted to clinical studies, to a matrix model involving both external and internal resources, and then gradually moved the bulk of the work to CROs.”
Order a Purchase Report Copy at https://www.marketresearchnest.com/purchase.php?reportid=278211
According to the report, one of the major drivers for this market is Increase in R&D expenditure. The pharmaceutical market is witnessing a global surge in funding for clinical research to combat various rare diseases developing across the globe or to explore new therapies for existing conditions. In 2016, the pharmaceutical industry spent more than $150 billion on R&D.
Further, the report states that one of the major factors hindering the growth of this market is Rising cost of clinical trials. Clinical trial management has changed dramatically over the years and the rising costs of clinical trials is a concern. The cost of clinical trials increases because of many factors. For instance, drugs undergo a difficult and slow process during clinical trials. The initial difficulty is patient enrolment, which is followed by making sure patients continue the trial and do not drop out of the research study. Globally, various studies have been conducted to study the cost aspect of clinical trials and it has been found that in the US, the average cost per patient increased by over 150% during 2010-2015 whereas in the UK it was in the range of 85%-90%.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key questions answered in this report: What will the market size be in 2021 and what will the growth rate be; What are the key market trends; What is driving this market; What are the challenges to market growth; Who are the key vendors in this market space; What are the market opportunities and threats faced by the key vendors; What are the strengths and weaknesses of the key vendors;
Enquiry before Buying at
MarketResearchNest.com is the most comprehensive collection of market research products and services on the Web. We offer reports from almost all top publishers and update our collection on daily basis to provide you with instant online access to the world’s most complete and recent database of expert insights on industries, organizations, products, and trends.
Mr. Jeet Jain